Croatian Agency for Medicinal Products (HALMED) recalls medication due to clinical trial data integrity concerns

HALMED has ordered a nationwide recall of a specific medication from all pharmacies following an assessment that invalidated the credibility of underlying clinical trial data. It remains unclear which specific drug is affected or the extent of the data discrepancies, but the recall necessitates immediate patient-physician consultation to manage treatment transitions.